Oncopharmpod
CodeBreak200 And Elderly AML Survival
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:19:58
- More information
Informações:
Synopsis
CodeBreak200: docetaxel vs. sotorasib in 2nd-line metastatic NSCLC (KRAS-G12C). A new safety signal emerges. https://doi.org/10.1016/S0140-6736(23)00221-0 A new survival prediction model for elderly patients with AML not receiving intensive therapy. https://doi.org/10.1002/cncr.34609
